Saturday, April 28, 2018, is National Prescription Drug Take-Back day, when a number of collection sites around the country will be taking back unused and unwanted prescription drugs through the National Prescription Drug Take-Back Initiative. The program helps to keep these substances out of our environment (e.g., water supply), as well as keep them safe from children, teens and adults who might accidentally or intentionally look to use them inappropriately.
The Take-Back Initiative says: Continue reading “National Prescription Drug Take-Back Day : April 28”
Last week findings published in the Journal of the American Medical Association (JAMA) found that nearly one-third of FDA approved drugs from 2001 through 2010 had major safety issues years after the medications were made widely available to patients.
The study identified 123 drugs that had safety issues arise after FDA approval. Of those:
• 3 were withdrawn due to safety concerns.
• 61 had received boxed warnings about serious side effects (the strictest warning put in the labeling of prescription drugs or drug products by the FDA Continue reading “Concerns About FDA Approved Drugs”
Research is showing more connections between some medications and cognitive impairment.
Earlier this year, a study showed a link between proton pump inhibitor use and an increased risk of dementia among seniors. Now, researchers are also recommending that older adults avoid using over-the-counter products such as nighttime cold medicines, sleep aids, night-time pain relievers and antihistamine medications due to their links to cognitive impairment. Using brain imaging techniques, scientists at Indiana University School of Medicine, found lower metabolism and reduced brain sizes in study participants taking drugs known to have an anticholinergic (AC) effect, meaning they block acetylcholine, a chemical involved in the transmission of electrical impulses between nerve cells. Continue reading “More Links Between Medications and Cognitive Impairment”